TY - JOUR
T1 - Relation Between Cigarette Smoking and Heart Failure (from the Multiethnic Study of Atherosclerosis)
AU - Watson, Megan
AU - Dardari, Zeina
AU - Kianoush, Sina
AU - Hall, Michael E.
AU - DeFilippis, Andrew P.
AU - Keith, Rachel J.
AU - Benjamin, Emelia J.
AU - Rodriguez, Carlos J.
AU - Bhatnagar, Aruni
AU - Lima, Joao A.
AU - Butler, Javed
AU - Blaha, Michael J.
AU - Rifai, Mahmoud Al
N1 - Funding Information:
This research was supported by contracts N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168 and N01-HC-95169 from the NHLBI, Bethesda, Maryland and by grants UL1-TR-000040 and UL1-TR-001079 from NCRR, Bethesda, Maryland. Exam 1 and 5 Urinary Cotinine measurements are available to the MESA study courtesy of MESA Lung contract HL077612. Research reported in this work was supported by grant number 5P50HL120163 from the NHLBI and FDA Center for Tobacco Products (CTP), Silver Spring, Maryland. This research was supported by contracts N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168 and N01-HC-95169 from the NHLBI, Bethesda, Maryland and by grants UL1-TR-000040 and UL1-TR-001079 from NCRR, Bethesda, Maryland. Exam 1 and 5 Urinary Cotinine measurements are available to the MESA study courtesy of MESA Lung contract HL077612. Research reported in this work was supported by grant number 5P50HL120163 from the NHLBI and FDA Center for Tobacco Products (CTP), Silver Spring, Maryland. The authors thank the other investigators, staff, and participants of the MESA study for their valuable contributions. A full list of participating investigators and institutions can be found at http://www.mesa-nhlbi.org. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Food and Drug Administration. This research was supported by contracts N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168 and N01-HC-95169 from the NHLBI, Bethesda, Maryland and by grants UL1-TR-000040 and UL1-TR-001079 from NCRR, Bethesda, Maryland. Exam 1 and 5 Urinary Cotinine measurements are available to the MESA study courtesy of MESA Lung contract HL077612. Research reported in this work was supported by grant number 5P50HL120163 from the NHLBI and FDA Center for Tobacco Products (CTP), Silver Spring, Maryland.
Funding Information:
This research was supported by contracts N01-HC-95159 , N01-HC-95160 , N01-HC-95161 , N01-HC-95162 , N01-HC-95163 , N01-HC-95164 , N01-HC-95165 , N01-HC-95166 , N01-HC-95167 , N01-HC-95168 and N01-HC-95169 from the NHLBI, Bethesda, Maryland and by grants UL1-TR-000040 and UL1-TR-001079 from NCRR, Bethesda, Maryland . Exam 1 and 5 Urinary Cotinine measurements are available to the MESA study courtesy of MESA Lung contract HL077612. Research reported in this work was supported by grant number 5P50HL120163 from the NHLBI and FDA Center for Tobacco Products (CTP), Silver Spring, Maryland.
Publisher Copyright:
© 2019 Elsevier Inc.
PY - 2019/6/15
Y1 - 2019/6/15
N2 - We studied the association between cigarette smoking and incident heart failure (HF) in a racially diverse US cohort. We included 6,792 participants from the Multi-Ethnic Study of Atherosclerosis with information on cigarette smoking at baseline, characterized by status, intensity, burden, and time since quitting. Adjudicated outcomes included total incident HF cases and HF stratified by ejection fraction (EF) into HF with reduced EF (HFrEF; EF ≤ 40%) and preserved EF (HFpEF; EF ≥ 50%). We used Cox proportional hazards models adjusted for traditional cardiovascular risk factors and accounted for competing risk of each HF type. Mean age was 62 ± 10 years; 53% were women, 61% were nonwhite, and 13% were current smokers. A total of 279 incident HF cases occurred over a median follow-up of 12.2 years. The incidence rates of HFrEF and HFpEF were 2.2 and 1.9 cases per 1000 person-years, respectively. Current smoking was associated with higher risk of HF compared with never smoking (hazard ratio [HR], 2.05; 95% confidence interval [CI], 1.36 to 3.09); this was similar for HFrEF (HR, 2.58; 95% CI, 1.27 to 5.25) and HFpEF (HR, 2.51; 95% CI, 1.15 to 5.49). Former smoking was not significantly associated with HF (HR, 1.17; 95% CI, 0.88 to 1.56). Smoking intensity, burden, and time since quitting did not provide additional information for HF risk after accounting for smoking status.
AB - We studied the association between cigarette smoking and incident heart failure (HF) in a racially diverse US cohort. We included 6,792 participants from the Multi-Ethnic Study of Atherosclerosis with information on cigarette smoking at baseline, characterized by status, intensity, burden, and time since quitting. Adjudicated outcomes included total incident HF cases and HF stratified by ejection fraction (EF) into HF with reduced EF (HFrEF; EF ≤ 40%) and preserved EF (HFpEF; EF ≥ 50%). We used Cox proportional hazards models adjusted for traditional cardiovascular risk factors and accounted for competing risk of each HF type. Mean age was 62 ± 10 years; 53% were women, 61% were nonwhite, and 13% were current smokers. A total of 279 incident HF cases occurred over a median follow-up of 12.2 years. The incidence rates of HFrEF and HFpEF were 2.2 and 1.9 cases per 1000 person-years, respectively. Current smoking was associated with higher risk of HF compared with never smoking (hazard ratio [HR], 2.05; 95% confidence interval [CI], 1.36 to 3.09); this was similar for HFrEF (HR, 2.58; 95% CI, 1.27 to 5.25) and HFpEF (HR, 2.51; 95% CI, 1.15 to 5.49). Former smoking was not significantly associated with HF (HR, 1.17; 95% CI, 0.88 to 1.56). Smoking intensity, burden, and time since quitting did not provide additional information for HF risk after accounting for smoking status.
UR - http://www.scopus.com/inward/record.url?scp=85063906233&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85063906233&partnerID=8YFLogxK
U2 - 10.1016/j.amjcard.2019.03.015
DO - 10.1016/j.amjcard.2019.03.015
M3 - Article
C2 - 30967285
AN - SCOPUS:85063906233
SN - 0002-9149
VL - 123
SP - 1972
EP - 1977
JO - American Journal of Cardiology
JF - American Journal of Cardiology
IS - 12
ER -